{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:28:52Z","timestamp":1793806132161,"version":"4.6.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,25]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>\n                      Spinocerebellar ataxia type 34 is a rare autosomal dominant ataxia associated with heterozygous elongation of very long-chain fatty acids protein 4 (\n                      <jats:italic toggle=\"yes\">ELOVL4<\/jats:italic>\n                      ) variants. Parkinsonism and severe early cognitive impairment are uncommon, and frameshift variants remain poorly characterized.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 35-year-old man presented with a 5-year history of progressive cognitive decline, bradykinesia, resting tremor, dysarthria, gait instability, and severe constipation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>\n                      Examination showed bilateral resting tremor, rigidity, limb and gait ataxia, and hyperreflexia. The Movement Disorder Society\u2013Unified Parkinson\u2019s Disease Rating Scale Part III score was 60, and the Scale for the Assessment and Rating of Ataxia score was 21. Cognitive testing showed severe impairment (Mini-Mental State Examination, 10; Montreal Cognitive Assessment, 8). Brain magnetic resonance imaging demonstrated marked cerebellar and generalized cerebral atrophy, and susceptibility-weighted imaging showed reduced dorsolateral nigral hyperintensity. Whole-exome sequencing identified a previously unreported heterozygous\n                      <jats:italic toggle=\"yes\">ELOVL4<\/jats:italic>\n                      frameshift variant, NM_022726.4:c.766_767delinsG (p.Ile256AlafsTer28). The clinical genetic testing report classified the variant as a variant of uncertain significance. Its predicted truncating effect and the patient\u2019s phenotypic overlap with\n                      <jats:italic toggle=\"yes\">ELOVL4<\/jats:italic>\n                      -related ataxia supported its consideration as a potentially clinically relevant candidate variant. However, Sanger confirmation and family segregation analysis were unavailable.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient received eperisone hydrochloride, levodopa\/benserazide, piribedil prolonged-release tablets, adenosyl cobalamin, and vitamin B1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>During 1 year of telephone and video follow-up, he reported mild improvement in tremor, gait difficulty, and rigidity, whereas dysarthria, slowing of eye movements, and constipation worsened. Repeat standardized assessments were unavailable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>\n                      This case describes a previously unreported\n                      <jats:italic toggle=\"yes\">ELOVL4<\/jats:italic>\n                      frameshift variant in a patient with cerebellar ataxia, parkinsonism, severe cognitive impairment, and autonomic dysfunction. Genetic testing may facilitate differentiation of hereditary ataxia from atypical degenerative syndromes. Additional molecular validation, segregation analysis, and functional studies are required to establish pathogenicity and genotype\u2013phenotype relationships.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050787","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:00:31Z","timestamp":1790359231000},"page":"e50787","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A previously unreported ELOVL4 frameshift variant in a patient with early severe cognitive decline, parkinsonism, and cerebellar ataxia"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4339-9458","authenticated-orcid":false,"given":"Jingtong","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Neurology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261104","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.parkreldis.2019.05.019","article-title":"Prevalence and clinicoradiological features of spinocerebellar ataxia type 34 in a Japanese ataxia cohort.","volume":"65","author":"Ozaki","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"R2-20261104","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.preteyeres.2018.10.004","article-title":"ELOVL4: very long-chain fatty acids serve an eclectic role in mammalian health and function.","volume":"69","author":"Hopiavuori","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"R3-20261104","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1167\/iovs.09-5134","article-title":"Retinal sphingolipids and their very-long-chain fatty acid-containing species.","volume":"51","author":"Brush","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R4-20261104","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1167\/iovs.04-0078","article-title":"A novel mutation in the ELOVL4 gene causes autosomal dominant Stargardt-like macular dystrophy.","volume":"45","author":"Maugeri","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R5-20261104","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.preteyeres.2010.01.001","article-title":"Genetics and molecular pathology of Stargardt-like macular degeneration.","volume":"29","author":"Vasireddy","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"R6-20261104","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ajhg.2011.10.011","article-title":"Recessive mutations in ELOVL4 cause ichthyosis, intellectual disability, and spastic quadriplegia.","volume":"89","author":"Aldahmesh","year":"2011","journal-title":"Am J Hum Genet"},{"key":"R7-20261104","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3390\/genes12030343","article-title":"Two Italian patients with ELOVL4-related neuro-ichthyosis: expanding the genotypic and phenotypic spectrum and ultrastructural characterization.","volume":"12","author":"Diociaiuti","year":"2021","journal-title":"Genes (Basel)"},{"key":"R8-20261104","doi-asserted-by":"crossref","first-page":"e2256","DOI":"10.1002\/mgg3.2256","article-title":"Expanding the allelic spectrum of ELOVL4-related autosomal recessive neuro-ichthyosis.","volume":"11","author":"Alabdulrazzaq","year":"2023","journal-title":"Mol Genet Genomic Med"},{"key":"R9-20261104","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s40478-023-01628-4","article-title":"A novel ELOVL4 variant, L168S, causes early childhood-onset spinocerebellar ataxia-34 and retinal dysfunction: a case report.","volume":"11","author":"Gyening","year":"2023","journal-title":"Acta Neuropathol Commun"},{"key":"R10-20261104","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jamaneurol.2015.0610","article-title":"A novel mutation in ELOVL4 leading to spinocerebellar ataxia (SCA) with the hot cross bun sign but lacking erythrokeratodermia: a broadened spectrum of SCA34.","volume":"72","author":"Ozaki","year":"2015","journal-title":"JAMA Neurol"},{"key":"R11-20261104","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1001\/jamaneurol.2015.0888","article-title":"A new ELOVL4 mutation in a case of spinocerebellar ataxia with erythrokeratodermia.","volume":"72","author":"Bourassa","year":"2015","journal-title":"JAMA Neurol"},{"key":"R12-20261104","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1212\/NXG.0000000000000263","article-title":"Novel ELOVL4 mutation associated with erythrokeratodermia and spinocerebellar ataxia (SCA34).","volume":"4","author":"Bourque","year":"2018","journal-title":"Neurol Genet"},{"key":"R13-20261104","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1212\/NXG.0000000000000403","article-title":"Characterization of the phenotype with cognitive impairment and protein mislocalization in SCA34.","volume":"6","author":"Beaudin","year":"2020","journal-title":"Neurol Genet"},{"key":"R14-20261104","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1212\/NXG.0000000000000357","article-title":"A family with spinocerebellar ataxia and retinitis pigmentosa attributed to an ELOVL4 mutation.","volume":"5","author":"Xiao","year":"2019","journal-title":"Neurol Genet"},{"key":"R15-20261104","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s12311-023-01522-8","article-title":"Two new families and a literature review of ELOVL4-associated spinocerebellar ataxia type 34.","volume":"23","author":"Nishide","year":"2024","journal-title":"Cerebellum"},{"key":"R16-20261104","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s40478-021-01272-w","article-title":"Neuropathology of SCA34 showing widespread oligodendroglial pathology with vacuolar white matter degeneration: a case study.","volume":"9","author":"Ozaki","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"R17-20261104","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00401-023-02582-0","article-title":"SCA34 caused by ELOVL4 L168F mutation is a lysosomal lipid storage disease sharing pathology features with neuronal ceroid lipofuscinosis and peroxisomal disorders.","volume":"146","author":"Ellezam","year":"2023","journal-title":"Acta Neuropathol"},{"key":"R18-20261104","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1523\/JNEUROSCI.0378-23.2023","article-title":"Synapse-specific defects in synaptic transmission in the cerebellum of W246G mutant ELOVL4 rats-a model of human SCA34.","volume":"43","author":"Nagaraja","year":"2023","journal-title":"J Neurosci"},{"key":"R19-20261104","doi-asserted-by":"crossref","first-page":"106983","DOI":"10.1016\/j.clineuro.2021.106983","article-title":"Rare mutation in ELOVL4 gene in SCA34 and cognitive affection: expounding the role of cerebellum.","volume":"210","author":"Mukherjee","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"R20-20261104","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neulet.2018.07.005","article-title":"The cerebellum and cognition.","volume":"688","author":"Schmahmann","year":"2019","journal-title":"Neurosci Lett"},{"key":"R21-20261104","doi-asserted-by":"crossref","first-page":"7554","DOI":"10.1523\/JNEUROSCI.1451-23.2023","article-title":"Cognitive-affective functions of the cerebellum.","volume":"43","author":"Rudolph","year":"2023","journal-title":"J Neurosci"},{"key":"R22-20261104","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1148\/radiol.2021203341","article-title":"Imaging the substantia nigra in Parkinson disease and other Parkinsonian syndromes.","volume":"300","author":"Bae","year":"2021","journal-title":"Radiology"},{"key":"R23-20261104","doi-asserted-by":"crossref","first-page":"117581","DOI":"10.1016\/j.jns.2021.117581","article-title":"The evaluation of the swallow tail sign in patients with parkinsonism and gait disorders.","volume":"428","author":"Kim","year":"2021","journal-title":"J Neurol Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:00:57Z","timestamp":1793804457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050787"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":23,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050787","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"2025-09-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}